Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PepGen Inc. | EVP, Res. & Preclin. Dev. | Stock Option (Right to Buy) | 144K | Mar 24, 2023 | Direct | ||
PepGen Inc. | EVP, Res. & Preclin. Dev. | Common Stock | 0 | $4.17 | Mar 24, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PEPG | PepGen Inc. | Mar 24, 2023 | 3 | -$3.58K | 4 | Mar 28, 2023 | EVP, Res. & Preclin. Dev. |
PEPG | PepGen Inc. | Mar 1, 2023 | 1 | $0 | 4 | Mar 2, 2023 | EVP, Res. & Preclin. Dev. |
PEPG | PepGen Inc. | Feb 6, 2023 | 9 | -$37.4K | 4 | Feb 8, 2023 | EVP, Res. & Preclin. Dev. |
PEPG | PepGen Inc. | May 6, 2022 | 1 | $0 | 4 | May 10, 2022 | Ex. VP. Research & Preclinical Development |
PEPG | PepGen Inc. | May 5, 2022 | 0 | $0 | 3 | May 5, 2022 | Ex. VP. Research & Preclinical Development Exhibit 24: Power of Attorney |